Clinical trial
Treatment of Multiple Sclerosis Using Over the Counter Inosine
NCT00067327 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00067327 |
|---|---|
| Title | Treatment of Multiple Sclerosis Using Over the Counter Inosine |
| Official title | Treatment of Multiple Sclerosis Using Over the Counter Inosine |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis, Relapsing-Remitting |
| Intervention type | Drug |
| Interventions | Inosine |
| Enrollment | 30 |
| Start date | Feb 1, 2002 |
| Completion | Sep 1, 2005 |
| First posted | Aug 19, 2003 |
| Last update posted | Mar 17, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: